Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria C Hodgkinson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Proteomics|February 23, 2011
Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysisVictoria C Hodgkinson, Dalia ElFadl, Philip J Drew, et al.
Expert Review of Proteomics|August 9, 2011
Differential proteomics in the search for biomarkers of radiotherapy resistanceLucy Scaife, Victoria C Hodgkinson, Philip J Drew, et al.
Cancer Letters|February 24, 2010
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current statusVictoria C Hodgkinson, Gina L Eagle, Philip J Drew, et al.
International Journal of Oncology|January 23, 2013
Proteomic (antibody microarray) exploration of the molecular mechanism of action of the specific COX-2 inhibitor DuP 697Vijay Agarwal, Victoria C Hodgkinson, Gina L Eagle, et al.
Breast (Edinburgh, Scotland)|March 18, 2011
A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancerDalia Elfadl, Victoria C Hodgkinson, Ervine D Long, et al.
Journal of Proteomics|April 14, 2012
Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancerVictoria C Hodgkinson, Vijay Agarwal, Dalia ELFadl, et al.
Journal of Proteomics|November 26, 2011
Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID?Victoria C Hodgkinson, Dalia ELFadl, Vijay Agarwal, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Proteomics|February 23, 2011
Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysisVictoria C Hodgkinson, Dalia ElFadl, Philip J Drew, et al.
Expert Review of Proteomics|August 9, 2011
Differential proteomics in the search for biomarkers of radiotherapy resistanceLucy Scaife, Victoria C Hodgkinson, Philip J Drew, et al.
Cancer Letters|February 24, 2010
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current statusVictoria C Hodgkinson, Gina L Eagle, Philip J Drew, et al.
International Journal of Oncology|January 23, 2013
Proteomic (antibody microarray) exploration of the molecular mechanism of action of the specific COX-2 inhibitor DuP 697Vijay Agarwal, Victoria C Hodgkinson, Gina L Eagle, et al.
Breast (Edinburgh, Scotland)|March 18, 2011
A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancerDalia Elfadl, Victoria C Hodgkinson, Ervine D Long, et al.
Journal of Proteomics|April 14, 2012
Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancerVictoria C Hodgkinson, Vijay Agarwal, Dalia ELFadl, et al.
Journal of Proteomics|November 26, 2011
Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID?Victoria C Hodgkinson, Dalia ELFadl, Vijay Agarwal, et al.
Pageof 1